Versartis Inc. | Mutual Funds
Mutual Funds that own Versartis Inc.
Vanguard Total Stock Market Index Fund
676,069
1.87%
0
0%
07/31/2018
Vanguard Extended Market Index Fund
343,568
0.95%
0
0%
07/31/2018
DFA US Targeted Value Portfolio
192,676
0.53%
6,083
0%
04/30/2018
Bridgeway Small Cap Growth Fund
115,473
0.32%
-248,027
0.32%
03/31/2018
Fidelity Spartan Extended Market Index Fund
107,155
0.3%
0
0%
07/31/2018
iShares Micro Cap ETF
95,170
0.26%
0
0.02%
09/06/2018
Schwab US Small Cap ETF
74,160
0.21%
0
0%
09/06/2018
Fidelity Spartan Small Cap Index Fund
66,993
0.19%
1,266
0%
04/30/2018
DFA US Micro Cap Portfolio
65,267
0.18%
0
0%
04/30/2018
DFA US Small Cap Portfolio
60,818
0.17%
6,761
0%
04/30/2018
| Address |
1020 Marsh Roade
Menlo Park California 94025
United States
|
|
Employees
|
- |
| Website |
http://www.versartis.com |
| Updated |
09/14/2018 |
| Versartis, Inc. is an endocrine-focused biopharmaceutical company, which engages in the research and development of pharmaceutical products. Its portfolio includes Somavartan and XTEN TEchnology which target the endocrine disorders and growth hormone deficiencies. The company was founded by Jeffrey L. |
